Respiratory Syncytial Virus (RSV) Infection Clinical Trials

A listing of Respiratory Syncytial Virus (RSV) Infection medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
featured
VAD00001: Respiratory Syncytial Virus (RSV) Study  

The primary objectives of the study are: To assess the safety profile of each dose of the study product after each and any administration in all infants and toddlers regardless of baseline neutralizing antibody serostatus. To characterize the RSV-A serum neutralizing antibody responses to the study product in each vaccine …

  • 14 views
  • 28 Jul, 2021
  • 17 locations
A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Late Preterm and Term Infants

The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and antidrug antibody (ADA) response for MEDI8897 in healthy late preterm and term infants who are 35 weeks or greater gestational age and entering their first RSV season.

  • 574 views
  • 28 Jul, 2021
  • 405 locations
Efficacy and Safety of MK-1654 in Infants (MK-1654-004)

The primary objectives of this phase 2b/3 double-blind, randomized, placebo-controlled study are to evaluate the efficacy and safety of MK-1654 in healthy pre-term and full-term infants. It is hypothesized that MK-1654 will reduce the incidence of respiratory syncytial virus (RSV)-associated medically attended lower respiratory infection (MALRI) from Days 1 through …

  • 0 views
  • 01 Aug, 2021
  • 28 locations
A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

The purpose of the study is to evaluate the efficacy of rilematovir compared to placebo treatment with respect to the clinical outcome on the RSV Recovery Scale (RRS).

fever
cough
congestion
nasal congestion
rsv infection
  • 0 views
  • 01 Aug, 2021
  • 209 locations
Study of a Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

The primary objectives of the study are: To assess the safety profile of each dose of the study product after each and any administration in all infants and toddlers regardless of baseline neutralizing antibody serostatus. To characterize the RSV-A serum neutralizing antibody responses to the study product in each vaccine …

vaccination
respiratory syncytial virus vaccines
  • 0 views
  • 31 Jul, 2021
  • 27 locations
Evaluate the Safety and Tolerability for Nirsevimab in Immunocompromised Children

Study D5290C00008 is a Phase 2, open-label, uncontrolled, single-dose study to evaluate the safety and tolerability, PK, occurrence of ADA, and efficacy of nirsevimab in immunocompromised Japanese children who are 24 months of age at the time of dose administration. Approximately 30 subjects will be enrolled. Subjects will be followed …

wiskott-aldrich syndrome
HIV Infection
corticosteroid therapy
immunodeficiency
methotrexate
  • 15 views
  • 20 Jul, 2021
  • 9 locations